Prospective cohort study of fatigue before and after SARS-CoV-2 infection in the Netherlands

Anne J. Huiberts, Siméon Bruijn, Stijn P. Andeweg, Christina E. Hoeve, Maarten Schipper, Hester E. Melker, Janneke HHM Wijgert, Susan Hof, Cees C. Wijngaard and Mirjam J. Knol ()
Additional contact information
Anne J. Huiberts: National Institute for Public Health and Environment (RIVM)
Siméon Bruijn: National Institute for Public Health and Environment (RIVM)
Stijn P. Andeweg: National Institute for Public Health and Environment (RIVM)
Christina E. Hoeve: National Institute for Public Health and Environment (RIVM)
Maarten Schipper: National Institute for Public Health and Environment (RIVM)
Hester E. Melker: National Institute for Public Health and Environment (RIVM)
Janneke HHM Wijgert: University Medical Center Utrecht (UMCU)
Susan Hof: National Institute for Public Health and Environment (RIVM)
Cees C. Wijngaard: National Institute for Public Health and Environment (RIVM)
Mirjam J. Knol: National Institute for Public Health and Environment (RIVM)

Nature Communications, 2025, vol. 16, issue 1, 1-10

Abstract: Abstract Fatigue is one of the most common persistent symptoms of SARS-CoV-2 infection. We aimed to assess fatigue during and after a SARS-CoV-2 infection by age, sex, presence of a medical risk condition, SARS-CoV-2 variant and vaccination status, accounting for pre-infection fatigue and compared with uninfected individuals. We used data from an ongoing prospective cohort study in the Netherlands (VASCO). We included 22,705 first infections reported between 12 July 2021 and 9 March 2024. Mean fatigue scores increased during infection, declined rapidly in the first 90 days post-infection, but remained elevated until at least 270 days for Delta and 120 days for Omicron infections. Prevalence of severe fatigue was 18.5% before first infection. It increased to 24.4% and 22.5% during acute infection and decreased to 21.2% and 18.9% at 90 days after Delta and Omicron infection, respectively. The prevalence among uninfected participants was lower than among matched Delta-infected participants during the acute phase of the infection and 90 days post-infection. For matched Omicron-infected individuals this was only observed during the acute phase. We observed no differences in mean post- vs pre-infection fatigue scores at 90-270 days post-infection by vaccination status. The impact of SARS-CoV-2 infection on the prevalence of severe fatigue was modest at population level, especially for Omicron.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-56994-5 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56994-5

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-56994-5

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().